Milani, P., Schönland, S., Kimmich, C., Bochtler, T., Ho, A. D., & Hegenbart, U. (2017). Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis. Amyloid, 24(sup1), . https://doi.org/10.1080/13506129.2017.1292240
Chicago-Zitierstil (17. Ausg.)Milani, Paolo, Stefan Schönland, Christoph Kimmich, Tilmann Bochtler, Anthony Dick Ho, und Ute Hegenbart. "Response to Bendamustine Is Associated with a Survival Advantage in a Heavily Pretreated Patients with AL Amyloidosis." Amyloid 24, no. sup1 (2017). https://doi.org/10.1080/13506129.2017.1292240.
MLA-Zitierstil (9. Ausg.)Milani, Paolo, et al. "Response to Bendamustine Is Associated with a Survival Advantage in a Heavily Pretreated Patients with AL Amyloidosis." Amyloid, vol. 24, no. sup1, 2017, https://doi.org/10.1080/13506129.2017.1292240.